Press Releases

The Board of Directors approves the net financial position for the first quarter of 2021

May 12, 2021

The Board of Directors approves the net financial position for the first quarter of 2021 in the amount of 104,668 thousand euro, and acknowledges the progress of the main clinical trials on Nidlegy™ and Fibromun in line with the expected timelines (Price Sensitive)

Last Press Releases
Jul20212
Philogen Announces R&D Program Update
Jun202129
Deposito del Verbale dell'Assemblea degli Azionisti (Price sensitive)
  • 1
  • 2
  • 3
  • …
  • 5
  • Next »

Attachments

  • Original document
  • Permalink

Disclaimer

Philogen S.p.A. published this content on 02 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 July 2021 17:32:22 UTC.